Free Trial
→ PH: Do THESE 4 things to your bank account now … (From Weiss Ratings) (Ad)tc pixel Free THMO Stock Alerts

ThermoGenesis (THMO) Competitors

ThermoGenesis logo
Compare

THMO vs. TBIO, HTGMQ, OLITW, PRENW, and QSIAW

Should you buy ThermoGenesis stock or one of its competitors? MarketBeat compares ThermoGenesis with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with ThermoGenesis include Telesis Bio (TBIO), HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), and Quantum-Si (QSIAW). These companies are all part of the "measuring and control equipment" industry.

How does ThermoGenesis compare to Telesis Bio?

Telesis Bio (NASDAQ:TBIO) and ThermoGenesis (NASDAQ:THMO) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, risk, valuation, profitability and institutional ownership.

ThermoGenesis has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%.

Company Net Margins Return on Equity Return on Assets
Telesis Bio-336.59% N/A -61.89%
ThermoGenesis N/A N/A N/A

Telesis Bio has a beta of 2.29, indicating that its share price is 129% more volatile than the broader market. Comparatively, ThermoGenesis has a beta of 1.1, indicating that its share price is 10% more volatile than the broader market.

In the previous week, Telesis Bio's average media sentiment score of 0.00 equaled ThermoGenesis'average media sentiment score.

Company Overall Sentiment
Telesis Bio Neutral
ThermoGenesis Neutral

37.6% of Telesis Bio shares are held by institutional investors. Comparatively, 5.8% of ThermoGenesis shares are held by institutional investors. 24.5% of Telesis Bio shares are held by company insiders. Comparatively, 78.0% of ThermoGenesis shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

ThermoGenesis has lower revenue, but higher earnings than Telesis Bio. Telesis Bio is trading at a lower price-to-earnings ratio than ThermoGenesis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Telesis Bio$225.09M0.00-$47.72M-$20.52N/A
ThermoGenesis$9.61M0.00-$17.98M-$5.14N/A

Summary

ThermoGenesis beats Telesis Bio on 6 of the 9 factors compared between the two stocks.

How does ThermoGenesis compare to HTG Molecular Diagnostics?

HTG Molecular Diagnostics (NASDAQ:HTGMQ) and ThermoGenesis (NASDAQ:THMO) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment.

5.8% of ThermoGenesis shares are owned by institutional investors. 2.6% of HTG Molecular Diagnostics shares are owned by company insiders. Comparatively, 78.0% of ThermoGenesis shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

HTG Molecular Diagnostics has a beta of 3.25, suggesting that its stock price is 225% more volatile than the broader market. Comparatively, ThermoGenesis has a beta of 1.1, suggesting that its stock price is 10% more volatile than the broader market.

Company Net Margins Return on Equity Return on Assets
HTG Molecular DiagnosticsN/A N/A N/A
ThermoGenesis N/A N/A N/A

In the previous week, HTG Molecular Diagnostics' average media sentiment score of 0.00 equaled ThermoGenesis'average media sentiment score.

Company Overall Sentiment
HTG Molecular Diagnostics Neutral
ThermoGenesis Neutral

ThermoGenesis has higher revenue and earnings than HTG Molecular Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HTG Molecular Diagnostics$6.37M0.00-$21.59M-$2.28N/A
ThermoGenesis$9.61M0.00-$17.98M-$5.14N/A

Summary

ThermoGenesis beats HTG Molecular Diagnostics on 5 of the 7 factors compared between the two stocks.

How does ThermoGenesis compare to OmniLit Acquisition?

OmniLit Acquisition (NASDAQ:OLITW) and ThermoGenesis (NASDAQ:THMO) are both measuring and control equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, dividends, analyst recommendations, profitability, earnings and valuation.

5.8% of ThermoGenesis shares are owned by institutional investors. 78.0% of ThermoGenesis shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

OmniLit Acquisition has higher earnings, but lower revenue than ThermoGenesis.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OmniLit AcquisitionN/AN/AN/AN/AN/A
ThermoGenesis$9.61M0.00-$17.98M-$5.14N/A

Company Net Margins Return on Equity Return on Assets
OmniLit AcquisitionN/A N/A N/A
ThermoGenesis N/A N/A N/A

In the previous week, OmniLit Acquisition's average media sentiment score of 0.00 equaled ThermoGenesis'average media sentiment score.

Company Overall Sentiment
OmniLit Acquisition Neutral
ThermoGenesis Neutral

Summary

ThermoGenesis beats OmniLit Acquisition on 3 of the 3 factors compared between the two stocks.

How does ThermoGenesis compare to Prenetics Global?

Prenetics Global (NASDAQ:PRENW) and ThermoGenesis (NASDAQ:THMO) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends.

5.8% of ThermoGenesis shares are owned by institutional investors. 78.0% of ThermoGenesis shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Prenetics Global has higher revenue and earnings than ThermoGenesis.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Prenetics Global$92.39MN/AN/AN/AN/A
ThermoGenesis$9.61M0.00-$17.98M-$5.14N/A

Company Net Margins Return on Equity Return on Assets
Prenetics GlobalN/A N/A N/A
ThermoGenesis N/A N/A N/A

In the previous week, Prenetics Global's average media sentiment score of 0.00 equaled ThermoGenesis'average media sentiment score.

Company Overall Sentiment
Prenetics Global Neutral
ThermoGenesis Neutral

Summary

ThermoGenesis beats Prenetics Global on 2 of the 3 factors compared between the two stocks.

How does ThermoGenesis compare to Quantum-Si?

ThermoGenesis (NASDAQ:THMO) and Quantum-Si (NASDAQ:QSIAW) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, dividends, media sentiment, earnings, institutional ownership and valuation.

Company Net Margins Return on Equity Return on Assets
ThermoGenesisN/A N/A N/A
Quantum-Si N/A N/A N/A

5.8% of ThermoGenesis shares are owned by institutional investors. 78.0% of ThermoGenesis shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Quantum-Si has lower revenue, but higher earnings than ThermoGenesis.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ThermoGenesis$9.61M0.00-$17.98M-$5.14N/A
Quantum-Si$1.85MN/AN/AN/AN/A

In the previous week, ThermoGenesis' average media sentiment score of 0.00 equaled Quantum-Si'saverage media sentiment score.

Company Overall Sentiment
ThermoGenesis Neutral
Quantum-Si Neutral

Summary

ThermoGenesis beats Quantum-Si on 3 of the 3 factors compared between the two stocks.

Get ThermoGenesis News Delivered to You Automatically

Sign up to receive the latest news and ratings for THMO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding THMO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

THMO vs. The Competition

Export
MetricThermoGenesisLaboratory apparatus & furniture IndustryMedical SectorNASDAQ Exchange
Market Cap$1K$1K$6.46B$12.34B
Dividend YieldN/AN/A2.76%5.28%
P/E Ratio0.00N/A20.9925.66
Price / SalesN/A0.00556.5686.31
Price / CashN/AN/A43.4956.67
Price / BookN/AN/A10.447.14
Net Income-$17.98M-$17.98M$3.57B$335.98M

ThermoGenesis Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
THMO
ThermoGenesis
N/AN/AN/AN/A$1K$9.61MN/A40
TBIO
Telesis Bio
N/A$0.00
flat		N/AN/A$2K$225.09MN/A200
HTGMQ
HTG Molecular Diagnostics
N/AN/AN/AN/A$0.00$6.37MN/A90
OLITW
OmniLit Acquisition
N/A$1.15
+16.2%		N/A+2,306.9%$0.00N/AN/A3
PRENW
Prenetics Global
N/A$0.02
-0.6%		N/A+6.2%$0.00$92.39MN/A1

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:THMO) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
The SpaceX supplier that shipped 5 billion chips to Starlink
When Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...
Weiss Ratings | Sponsoredtc pixel
Three companies about to leapfrog Nvidia [And transform the entire industry]
Futurist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...
Eagle Publishing | Sponsoredtc pixel
June 4: The day smart money moves (not June 12)
Everyone is watching June 12 - the SpaceX listing date. The real deadline is June 4, when Goldman Sachs, Morga...
Behind the Markets | Sponsoredtc pixel
My crisis of conscience
Emmet Savage - named in Irish America's Wall Street 50 as one of the most successful investors in the world - ...
Porter & Company | Sponsoredtc pixel
Your book attached
Bill Poulos is offering his 'Simple Options Trading For Beginners' guide at no cost - normally priced at $29.9...
Profits Run | Sponsoredtc pixel
Skip the Line Opportunity: The SpaceX IPO
Former tech executive and angel investor Jeff Brown - who identified Bitcoin, Tesla, and Nvidia before their h...
Brownstone Research | Sponsoredtc pixel